Delivery Order SPE2DB24D2011-SPE2DB24FBPJL

Award Date 4/11/24
Potential Completion Date 4/12/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,095.55 firm fixed-price delivery order is for the supply of the vaccine Typhim VI 25 mcg/0.5 mL vial in 10 mL quantities. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,502.31 firm-fixed-price delivery order is for the supply of 4,563,458,750 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The contract has an ultimate completion date of January 29, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $48,434.00 firm fixed-price delivery order is for the vaccine Typhim VI 25 mcg/0.5 mL vial, 10 mL, with a completion date of December 17, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,890.41, is for the delivery of the vaccine Typhim VI (25 mcg/0.5 mL vial) with a completion date of March 29, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML vaccines. The contract has a ceiling value of $3,421.00 and a performance period through March 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds as the sole prime...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $5,617.86 contract is for the provision of 4,563,955,495 units of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,942.96, is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract is a Firm Fixed Price Delivery Order with a completion date of January 14, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is the prime contractor, and the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $8,347.20, is for the delivery of the vaccine TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This is a firm fixed-price delivery order contract with a completion date of May 9, 2024. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is the prime contractor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,417.05 firm fixed-price delivery order is for the supply of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a vaccine product. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a...
This federal contract award, valued at $1,368.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,296,769 units of the Typhim VI 25 MCG/0.5 ML SYRNG 0.5ML vaccine. This is a firm fixed-price delivery order contract with an ultimate completion date of April 17, 2024. The contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds...
  • SPE2DB24D2011
    Indefinite Delivery Contract
  • SPE2DB24D2011-SPE2DB24FBPJL
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,365.04 firm fixed price delivery order is for the supply of the vaccine Typhim VI 25 mcg/0.5 mL syringe 0.5mL. The contract has an ultimate completion date of April 12, 2024.

Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award does not utilize any set-aside designations.

Generated 7/11/24, 9:05 AM